SHARLA CARROLL: Open Payments
NPI 1689739278 · EASTLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 42 payments from 18 companies in 2025. Trend: 2023 $763 · 2024 $741 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $226 |
| Astellas Pharma US Inc | 3 | $68 |
| JAZZ PHARMACEUTICALS INC. | 2 | $59 |
| Novo Nordisk Inc | 3 | $50 |
| Soleno Therapeutics, Inc. | 2 | $46 |
| Abbott Laboratories | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 5 | $38 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Lilly USA, LLC | 2 | $28 |
Products named: BREZTRI, AIRSUPRA, Veozah, FARXIGA, EPIDIOLEX, Ozempic, VYKAT XR, FREESTYLE LIBRE.
Industry payments across TX — which companies pay providers there.
